Literature DB >> 21467541

A comparison of mortality and cardiac biomarker response between three outbred stocks of Sprague Dawley rats treated with isoproterenol.

A Eric Schultze1, Bradley W Main, D Greg Hall, Wherly P Hoffman, H-Y Cindy Lee, Bradley L Ackermann, Michael L Pritt, Holly W Smith.   

Abstract

The authors compared the mortality and cardiac biomarker responses in three outbred stocks of Sprague Dawley rats (CD/IGS, Sasco, Harlan) treated with isoproterenol hydrochloride. Cardiac injury was confirmed by histologic evaluation, and increases in cardiac troponin I concentration in serum were measured by two methods. CD/IGS rats had a higher incidence and earlier mortality compared with Sasco or Harlan rats. Harlan rats had lower severity scores for cardiomyocyte degeneration/necrosis compared with the other stocks. Post-isoproterenol treatment cardiac troponin I concentrations were greater in CD/IGS and Sasco rats compared with Harlan rats. Concentrations of cardiac troponin T followed a similar pattern to that of cardiac troponin I in rats treated with isoproterenol. Myosin, light chain 3 concentrations increased in all rats treated with isoproterenol, but there was no difference between the three stocks in the magnitude or pattern of the dose response. Increases in fatty acid binding protein 3 concentrations were detected in only the highest dose group at the earliest timepoint postdose for all three stocks of rats. Results of these studies illustrate the need for investigators to recognize the potential differences in response between stocks of Sprague Dawley rats treated with cardiotoxicants or novel chemical entities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467541     DOI: 10.1177/0192623311402219

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  2 in total

1.  Differential analysis of transient increases of serum cTnI in response to handling in rats.

Authors:  Igor Mikaelian; Michael E Dunn; Diane R Mould; Gerard Hirkaler; Wanping Geng; Denise Coluccio; Rosemary Nicklaus; Thomas Singer; Micaela Reddy
Journal:  Pharmacol Res Perspect       Date:  2013-12-05

2.  Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models.

Authors:  Aurélien Frobert; Jérémy Valentin; Jean-Luc Magnin; Erwin Riedo; Stéphane Cook; Marie-Noëlle Giraud
Journal:  Front Physiol       Date:  2015-11-27       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.